Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,296Revenue $M309Net Margin (%)-36.0Altman Z-Score11.4
Enterprise Value $M5,046EPS $-0.9Operating Margin %-36.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-36.0Higher ROA y-yN
Price/Book29.610-y EBITDA Growth Rate %-4.9Quick Ratio2.3Cash flow > EarningsY
Price/Sales17.05-y EBITDA Growth Rate %-12.7Current Ratio2.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-24.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-53.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M125ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SGENVanguard Health Care Fund 2015-06-30 Buy 0.02%$34.03 - $49.63
$ 42.253%New holding170,125
SGENFirst Eagle Investment 2010-03-31 Sold Out -0.01%$9.34 - $12.59
$ 42.25290%Sold Out0
SGENFirst Eagle Investment 2009-12-31 Buy 0.01%$8.74 - $13.16
$ 42.25336%New holding67,373
SGENBill Gates 2009-09-30 Sold Out -0.39%$8.75 - $14.8
$ 42.25261%Sold Out0
SGENFirst Eagle Investment 2009-06-30 Sold Out -0.01%$8.18 - $10.34
$ 42.25365%Sold Out0
SGENFirst Eagle Investment 2009-03-31 Add$7.23 - $10.36
$ 42.25349%Add 40.00%70,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

SGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIEGALL CLAY BPresident and CEO 2015-08-20Sell31,754$42.020.55view
DOBMEIER ERICCOO 2015-08-20Sell8,548$42.020.55view
DRACHMAN JONATHAN GCMO & EVP, R & D 2015-08-20Sell4,462$42.020.55view
Cline Darren SSVP, Commercial 2015-08-20Sell2,231$42.020.55view
SIMPSON TODD ECFO 2015-08-20Sell5,825$42.020.55view
HIMES VAUGHN BEVP, Proc Svcs & Tech Ops 2015-08-20Sell5,997$42.020.55view
SIEGALL CLAY BPresident and CEO 2015-08-05Sell3,718$46.91-9.93view
SIEGALL CLAY BPresident and CEO 2015-07-06Sell3,718$46.94-9.99view
SIEGALL CLAY BPresident and CEO 2015-06-03Sell3,718$45.72-7.59view
BAKER FELIXDirector, 10% Owner 2015-05-21Buy950,886$42.49-0.56view

Quarterly/Annual Reports about SGEN:

    News about SGEN:

    Articles On GuruFocus.com
    Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 
    Insiders keep on buying Macerich Co and Seattle Genetics May 22 2015 
    Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA May 12 2015 
    Seattle Genetics: Can Record Growth From Its Licenses Oct 28 2014 
    Seattle Genetics: Can Record Sustained Growth From Royalty Aug 31 2014 
    Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
    Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
    Comment for Companies Ranked by Business Predictability Jan 03 2013 
    Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN Sep 10 2012 

    More From Other Websites
    Seattle Genetics' Adcetris Label Expanded in the U.S. Aug 18 2015
    Seattle Genetics drug wins FDA approval, could boost biotech's revenue Aug 18 2015
    Sell Seattle Genetics' Latest Good News: Piper Jaffray Aug 18 2015
    SEATTLE GENETICS INC /WA Files SEC form 8-K, Other Events Aug 17 2015
    Seattle Genetics Announces FDA Regular Approval of ADCETRIS® (Brentuximab Vedotin) for Classical... Aug 17 2015
    3 Key Biotech Drug Approvals Expected This Month Aug 12 2015
    Takeda Pharmaceutical Co., Ltd. Earnings Q2*, 2015 Aug 12 2015
    Vanguard Health Care Fund Buys 2 New Stakes in Second Quarter Aug 06 2015
    SEATTLE GENETICS INC /WA Financials Aug 06 2015
    10-Q for Seattle Genetics, Inc. Aug 01 2015
    Seattle Genetics (SGEN) Loss Widens in Q2, Ups 2015 View - Analyst Blog Jul 31 2015
    Edited Transcript of SGEN earnings conference call or presentation 30-Jul-15 8:30pm GMT Jul 31 2015
    Seattle Genetics reports 2Q loss Jul 30 2015
    Seattle Genetics reports 2Q loss Jul 30 2015
    Seattle Genetics losses grow after deal with Boston company, R&D investments Jul 30 2015
    Seattle Genetics Inc Earnings Call scheduled for 4:30 pm ET today Jul 30 2015
    SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 30 2015
    Seattle Genetics Reports Second Quarter 2015 Financial Results Jul 30 2015
    Cramer: Receptos perfect fit for Celgene Jul 15 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)